Almotriptan
Generic name: Pronounced as (al moh trip' tan)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 03/15/2016
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Almotriptan is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels around the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks or reduce the number of headaches you have.
How should this medicine be used?
Almotriptan comes as a tablet to take by mouth. It is usually taken at the first sign of a migraine headache. If your symptoms improve after you take almotriptan but return after 2 hours or longer, you may take a second tablet. However, if your symptoms do not improve after you take almotriptan, do not take a second tablet before calling your doctor. Your doctor will tell you the maximum number of tablets you may take in a 24-hour period. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take almotriptan exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
You may take your first dose of almotriptan in a doctor's office or other medical facility where you can be monitored for serious reactions.
Call your doctor if your headaches do not get better or occur more frequently after taking almotriptan.
If you take almotriptan more often or for longer than the recommended period of time, your headaches may get worse or may occur more frequently. You should not take almotriptan or any other headache medication for more than 10 days per month. Call your doctor if you need to take almotriptan to treat more than four headaches in a 1-month period.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking almotriptan,
-
tell your doctor and pharmacist if you are allergic to almotriptan, any other medications, or any of the ingredients in almotriptan tablets. Ask your pharmacist for a list of the ingredients.
-
do not take almotriptan if you have taken any of the following medications in the past 24 hours: other selective serotonin receptor agonists such as eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), rizatriptan (Maxalt), sumatriptan (Imitrex, in Treximet), or zolmitriptan (Zomig); or ergot-type medications such as bromocriptine (Parlodel), cabergoline, dihydroergotamine (D.H.E. 45, Migranal), ergoloid mesylates (Hydergine), ergonovine (Ergotrate), ergotamine (Cafergot, Ergomar, Wigraine), methylergonovine (Methergine), methysergide (Sansert), and pergolide (Permax).
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking, have recently stopped taking, or plan to take. Be sure to mention any of the following: acetaminophen (Tylenol); aspirin and other nonsteroidal anti-inflammatory medications (NSAIDS) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); clarithromycin (Biaxin); indinavir (Crixivan); ; nefazodone (Serzone); selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, in Symbyax), fluvoxamine, paroxetine (Paxil), and sertraline (Zoloft); selective serotonin/norepinephrine reuptake inhibitors (SNRIs) such as desvenlafaxine (Pristiq), duloxetine (Cymbalta), sibutramine (Meridia), and venlafaxine (Effexor); troleandomycin (TAO); and zafirlukast (Accolate). Tell your doctor or pharmacist if you are taking the following medications or if you have stopped taking them within the past week: antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); erythromycin (E.E.S., E-Mycin, Erythrocin); and ritonavir (Norvir). Also tell your doctor or pharmacist if you are taking the following medications or if you have stopped taking them within the past 2 weeks: monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl), and tranylcypromine (Parnate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have or have ever had heart disease; a heart attack; angina (chest pain); irregular heartbeats; stroke or 'mini-stroke'; or circulation problems such as varicose veins, blood clots in the legs, Raynaud's disease (problems with blood flow to the fingers, toes, ears, and nose), or ischemic bowel disease (bloody diarrhea and stomach pain caused by decreased blood flow to the intestines). Your doctor may tell you not to take almotriptan.
-
tell your doctor if you smoke or are overweight; if you have or have ever had high blood pressure, high cholesterol, diabetes, or kidney or liver disease; if you have gone through menopause (change of life); or if any family members have or have ever had heart disease or stroke.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you plan to be sexually active while you are taking this medication, talk to your doctor about effective methods of birth control. If you become pregnant while taking almotriptan, call your doctor.
-
you should know that almotriptan may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
-
talk to your doctor about your headache symptoms to make sure they are caused by migraine. Almotriptan should not be used to treat hemiplegic or basilar migraine or headaches caused by other conditions (such as cluster headaches).
What special dietary instructions should I follow?
Talk to your doctor about drinking grapefruit juice while taking this medicine.
What side effects can this medication cause?
-
Almotriptan may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
upset stomach
-
nausea
-
drowsiness
-
headache
-
dry mouth
-
dizziness
-
-
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:
-
swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
-
hoarseness
-
hives
-
rash
-
itching
-
tightness, pain, pressure, or heaviness in the chest, throat, neck, or jaw
-
slow or difficult speech
-
faintness
-
weakness or numbness of an arm or leg
-
sudden or severe stomach pain
-
bloody diarrhea
-
rapid, pounding, or irregular heartbeat
-
shortness of breath
-
breaking out in a cold sweat
-
difficulty breathing or swallowing
-
paleness or blue color of the fingers and toes
-
pain, burning, or tingling in the hands or feet
-
-
Almotriptan may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor. Your blood pressure should be checked regularly.
You should keep a headache diary by writing down when you have headaches and when you take almotriptan.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Repaglinide | Repaglinide The metabolism of Almotriptan can be decreased when combined with Repaglinide. |
Montelukast | Montelukast The metabolism of Almotriptan can be decreased when combined with Montelukast. |
Delavirdine | Delavirdine The metabolism of Almotriptan can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Almotriptan can be decreased when combined with Nevirapine. |
Atorvastatin | Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Almotriptan. |
Dolasetron | Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Almotriptan. |
Candesartan | Candesartan The metabolism of Almotriptan can be decreased when combined with Candesartan. |
Cilostazol | Cilostazol Almotriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clopidogrel | Clopidogrel The metabolism of Almotriptan can be decreased when combined with Clopidogrel. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Almotriptan is combined with Diphenoxylate. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Fenofibrate | Fenofibrate Almotriptan may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine The risk or severity of adverse effects can be increased when Almotriptan is combined with Guanfacine. |
Magnesium Hydroxide | Magnesium Hydroxide Almotriptan may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Methylergonovine | Methylergonovine Methylergometrine may increase the vasoconstricting activities of Almotriptan. |
Mycophenolate | Mycophenolate Almotriptan may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Naratriptan | Naratriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Naratriptan. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Paregoric | Paregoric The metabolism of Almotriptan can be decreased when combined with Morphine. |
Penbutolol | Penbutolol The metabolism of Almotriptan can be decreased when combined with Acebutolol. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Almotriptan. |
Potassium | Potassium Potassium may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Prednisone may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ranitidine | Ranitidine The metabolism of Almotriptan can be decreased when combined with Ranitidine. |
Reserpine | Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Almotriptan. |
Rizatriptan | Rizatriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Rizatriptan. |
Sumatriptan | Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Almotriptan. |
Tacrolimus | Tacrolimus Tacrolimus may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Almotriptan. |
Zolmitriptan | Zolmitriptan The risk or severity of vasospastic reactions can be increased when Zolmitriptan is combined with Almotriptan. |
Ampicillin Injection | Ampicillin Injection Ampicillin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection Fluconazole may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Almotriptan. |
Levofloxacin Injection | Levofloxacin Injection Almotriptan may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Almotriptan. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of sedation can be increased when Almotriptan is combined with Metoclopramide. |
Metronidazole Injection | Metronidazole Injection The metabolism of Almotriptan can be decreased when combined with Metronidazole. |
Morphine Injection | Morphine Injection The metabolism of Almotriptan can be decreased when combined with Morphine. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Almotriptan may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The metabolism of Almotriptan can be decreased when combined with Zidovudine. |
Altretamine | Altretamine The metabolism of Almotriptan can be decreased when combined with Amphetamine. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Almotriptan. |
Ondansetron | Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Almotriptan. |
Granisetron | Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Almotriptan. |
Torsemide | Torsemide The metabolism of Almotriptan can be decreased when combined with Torasemide. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Almotriptan. |
Alosetron | Alosetron The risk or severity of adverse effects can be increased when Almotriptan is combined with Alosetron. |
Entacapone | Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Almotriptan. |
Eprosartan | Eprosartan Almotriptan may decrease the antihypertensive activities of Eprosartan. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Almotriptan can be decreased when combined with Hydroxychloroquine. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Oxcarbazepine | Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Almotriptan. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Telmisartan | Telmisartan Almotriptan may decrease the antihypertensive activities of Telmisartan. |
Temozolomide | Temozolomide Temozolomide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Zaleplon | Zaleplon Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Zaleplon. |
Anakinra | Anakinra The metabolism of Almotriptan can be increased when combined with Anakinra. |
Desloratadine | Desloratadine The risk or severity of adverse effects can be increased when Almotriptan is combined with Desloratadine. |
Linezolid | Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Almotriptan. |
Trimipramine | Trimipramine The metabolism of Almotriptan can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Almotriptan can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium. |
Perindopril | Perindopril Perindopril may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dutasteride | Dutasteride The risk or severity of hypertension can be increased when Almotriptan is combined with Dutasteride. |
Epinephrine Injection | Epinephrine Injection The risk or severity of hypertension can be increased when Epinephrine is combined with Almotriptan. |
Eplerenone | Eplerenone Almotriptan may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Escitalopram. |
Olmesartan | Olmesartan Almotriptan may decrease the antihypertensive activities of Olmesartan. |
Zonisamide | Zonisamide The metabolism of Almotriptan can be decreased when combined with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Almotriptan can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of adverse effects can be increased when Almotriptan is combined with Aripiprazole. |
Atomoxetine | Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Almotriptan. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Almotriptan is combined with Dexmethylphenidate. |
Atazanavir | Atazanavir The metabolism of Almotriptan can be decreased when combined with Atazanavir. |
Eletriptan | Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Almotriptan. |
Mefloquine | Mefloquine The metabolism of Almotriptan can be decreased when combined with Mefloquine. |
Emtricitabine | Emtricitabine Emtricitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Memantine | Memantine Almotriptan may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tegaserod | Tegaserod The metabolism of Tegaserod can be decreased when combined with Almotriptan. |
Tadalafil | Tadalafil Almotriptan may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Frovatriptan. |
Progesterone | Progesterone The metabolism of Almotriptan can be decreased when combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Almotriptan. |
Infliximab Injection | Infliximab Injection The metabolism of Almotriptan can be increased when combined with Infliximab. |
Protriptyline | Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Almotriptan. |
Rifaximin | Rifaximin The metabolism of Almotriptan can be increased when combined with Rifaximin. |
Duloxetine | Duloxetine The metabolism of Duloxetine can be decreased when combined with Almotriptan. |
Tinidazole | Tinidazole Tinidazole may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Trospium | Trospium Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Trospium. |
Bosentan | Bosentan Almotriptan may decrease the antihypertensive activities of Bosentan. |
Cefditoren | Cefditoren Cefdinir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cinacalcet | Cinacalcet The metabolism of Almotriptan can be decreased when combined with Cinacalcet. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Almotriptan can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The risk or severity of CNS depression can be increased when Almotriptan is combined with Eszopiclone. |
Ganciclovir | Ganciclovir Almotriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Ribavirin | Ribavirin Ribavirin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Solifenacin | Solifenacin Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Solifenacin. |
Valganciclovir | Valganciclovir Almotriptan may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The metabolism of Almotriptan can be decreased when combined with Voriconazole. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine The metabolism of Almotriptan can be decreased when combined with Amphetamine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Almotriptan can be decreased when combined with Peginterferon alfa-2b. |
Sodium Oxybate | Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Isocarboxazid | Isocarboxazid The metabolism of Almotriptan can be decreased when combined with Isocarboxazid. |
Ramelteon | Ramelteon The risk or severity of adverse effects can be increased when Almotriptan is combined with Ramelteon. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Almotriptan. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Almotriptan. |
Pregabalin | Pregabalin The therapeutic efficacy of Almotriptan can be increased when used in combination with Pregabalin. |
Deferasirox | Deferasirox The metabolism of Almotriptan can be decreased when combined with Deferasirox. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Almotriptan. |
Tipranavir | Tipranavir The metabolism of Tipranavir can be decreased when combined with Almotriptan. |
Felbamate | Felbamate The risk or severity of adverse effects can be increased when Almotriptan is combined with Felbamate. |
Ranolazine | Ranolazine The serum concentration of Almotriptan can be increased when it is combined with Ranolazine. |
Abatacept Injection | Abatacept Injection The metabolism of Almotriptan can be increased when combined with Abatacept. |
Rasagiline | Rasagiline The metabolism of Almotriptan can be decreased when combined with Rasagiline. |
Imatinib | Imatinib The metabolism of Almotriptan can be decreased when combined with Imatinib. |
Sitagliptin | Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Almotriptan. |
Varenicline | Varenicline Almotriptan may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Gefitinib | Gefitinib The metabolism of Almotriptan can be decreased when combined with Gefitinib. |
Albuterol | Albuterol Almotriptan may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone The risk or severity of adverse effects can be increased when Almotriptan is combined with Paliperidone. |
Bortezomib | Bortezomib The metabolism of Almotriptan can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection Clofarabine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Lubiprostone | Lubiprostone Almotriptan may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Posaconazole | Posaconazole The metabolism of Almotriptan can be decreased when combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Almotriptan can be decreased when combined with Primaquine. |
Aliskiren | Aliskiren Almotriptan may decrease the antihypertensive activities of Aliskiren. |
Darunavir | Darunavir The metabolism of Darunavir can be decreased when combined with Almotriptan. |
Pemetrexed Injection | Pemetrexed Injection Almotriptan may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of adverse effects can be increased when Almotriptan is combined with Dimenhydrinate. |
Lisdexamfetamine | Lisdexamfetamine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Lisdexamfetamine. |
Nabilone | Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Sorafenib | Sorafenib The metabolism of Almotriptan can be decreased when combined with Sorafenib. |
Dronabinol | Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Lapatinib | Lapatinib The metabolism of Almotriptan can be decreased when combined with Lapatinib. |
Levocetirizine | Levocetirizine The risk or severity of adverse effects can be increased when Almotriptan is combined with Levocetirizine. |
Pegaptanib Injection | Pegaptanib Injection Almotriptan may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Mexiletine | Mexiletine The metabolism of Almotriptan can be decreased when combined with Mexiletine. |
Azacitidine Injection | Azacitidine Injection Almotriptan may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Temsirolimus | Temsirolimus The metabolism of Almotriptan can be decreased when combined with Temsirolimus. |
Lenalidomide | Lenalidomide Lenalidomide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Almotriptan can be decreased when combined with Nilotinib. |
Bexarotene | Bexarotene The metabolism of Almotriptan can be decreased when combined with Bexarotene. |
Budesonide | Budesonide Almotriptan may decrease the excretion rate of Budesonide which could result in a higher serum level. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Almotriptan. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Almotriptan. |
Doripenem Injection | Doripenem Injection Almotriptan may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection Almotriptan may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level. |
Desvenlafaxine | Desvenlafaxine The risk or severity of adverse effects can be increased when Almotriptan is combined with Desvenlafaxine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nebivolol | Nebivolol Almotriptan may decrease the antihypertensive activities of Nebivolol. |
Tretinoin | Tretinoin The metabolism of Almotriptan can be decreased when combined with Tretinoin. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Almotriptan. |
Certolizumab Injection | Certolizumab Injection The metabolism of Almotriptan can be increased when combined with Certolizumab pegol. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Almotriptan may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Almotriptan. |
Midazolam | Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Almotriptan. |
Naltrexone Injection | Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Almotriptan. |
Dexrazoxane Injection | Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Eltrombopag | Eltrombopag The metabolism of Almotriptan can be decreased when combined with Eltrombopag. |
Milnacipran | Milnacipran The risk or severity of adverse effects can be increased when Almotriptan is combined with Milnacipran. |
Plerixafor Injection | Plerixafor Injection Almotriptan may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine. |
Betaxolol | Betaxolol The metabolism of Almotriptan can be decreased when combined with Betaxolol. |
Iloperidone | Iloperidone The risk or severity of adverse effects can be increased when Almotriptan is combined with Iloperidone. |
Prasugrel | Prasugrel Almotriptan may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Lacosamide | Lacosamide The risk or severity of adverse effects can be increased when Almotriptan is combined with Lacosamide. |
Everolimus | Everolimus The metabolism of Almotriptan can be decreased when combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Almotriptan. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Almotriptan. |
Pralatrexate Injection | Pralatrexate Injection Almotriptan may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Almotriptan. |
Saxagliptin | Saxagliptin Almotriptan may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Almotriptan may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Tapentadol | Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Topotecan | Topotecan Almotriptan may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Golimumab Injection | Golimumab Injection The metabolism of Almotriptan can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Almotriptan. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Almotriptan is combined with Asenapine. |
Vigabatrin | Vigabatrin The risk or severity of adverse effects can be increased when Almotriptan is combined with Vigabatrin. |
Pitavastatin | Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Almotriptan. |
Oxymorphone | Oxymorphone The risk or severity of adverse effects can be increased when Almotriptan is combined with Oxymorphone. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Almotriptan can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine Almotriptan may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Almotriptan. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Almotriptan. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Almotriptan is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection Acetaminophen may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Vilazodone | Vilazodone The metabolism of Vilazodone can be decreased when combined with Almotriptan. |
Ipilimumab Injection | Ipilimumab Injection Almotriptan may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Terbutaline may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Roflumilast | Roflumilast Almotriptan may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Rilpivirine | Rilpivirine The metabolism of Almotriptan can be decreased when combined with Rilpivirine. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Almotriptan can be increased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The metabolism of Almotriptan can be decreased when combined with Abiraterone. |
Rivaroxaban | Rivaroxaban Almotriptan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Ruxolitinib | Ruxolitinib Almotriptan may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Clobazam | Clobazam The metabolism of Almotriptan can be decreased when combined with Clobazam. |
Vemurafenib | Vemurafenib The metabolism of Almotriptan can be decreased when combined with Vemurafenib. |
Vismodegib | Vismodegib The metabolism of Almotriptan can be decreased when combined with Vismodegib. |
Deferiprone | Deferiprone Almotriptan may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Cabergoline | Cabergoline Cabergoline may increase the vasoconstricting activities of Almotriptan. |
Naloxone Injection | Naloxone Injection The metabolism of Almotriptan can be decreased when combined with Naloxone. |
Ambrisentan | Ambrisentan Almotriptan may decrease the antihypertensive activities of Ambrisentan. |
Fondaparinux Injection | Fondaparinux Injection Fondaparinux may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ezogabine | Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Almotriptan. |
Enzalutamide | Enzalutamide The metabolism of Almotriptan can be decreased when combined with Enzalutamide. |
Mirabegron | Mirabegron The metabolism of Mirabegron can be decreased when combined with Almotriptan. |
Regorafenib | Regorafenib The metabolism of Almotriptan can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Almotriptan can be decreased when combined with Bosutinib. |
Teriflunomide | Teriflunomide The metabolism of Almotriptan can be decreased when combined with Teriflunomide. |
Cabozantinib (thyroid cancer) | Cabozantinib (thyroid cancer) The metabolism of Almotriptan can be decreased when combined with Cabozantinib. |
Teduglutide Injection | Teduglutide Injection Almotriptan may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Alogliptin | Alogliptin Almotriptan may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Ponatinib | Ponatinib The metabolism of Almotriptan can be decreased when combined with Ponatinib. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Almotriptan is combined with Pomalidomide. |
Apixaban | Apixaban The metabolism of Apixaban can be decreased when combined with Almotriptan. |
Canagliflozin | Canagliflozin Almotriptan may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The metabolism of Almotriptan can be decreased when combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Almotriptan can be decreased when combined with Ospemifene. |
Trametinib | Trametinib The metabolism of Almotriptan can be decreased when combined with Trametinib. |
Levomilnacipran | Levomilnacipran The risk or severity of adverse effects can be increased when Almotriptan is combined with Levomilnacipran. |
Ertapenem Injection | Ertapenem Injection Ertapenem may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Almotriptan. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Almotriptan. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Sofosbuvir | Sofosbuvir Almotriptan may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Dapagliflozin may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast The metabolism of Almotriptan can be increased when combined with Apremilast. |
Droxidopa | Droxidopa Almotriptan may increase the hypertensive activities of Droxidopa. |
Siltuximab Injection | Siltuximab Injection The metabolism of Almotriptan can be increased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine The risk or severity of adverse effects can be increased when Almotriptan is combined with Eslicarbazepine. |
Testosterone Injection | Testosterone Injection Testosterone may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Oritavancin Injection | Oritavancin Injection The metabolism of Almotriptan can be decreased when combined with Oritavancin. |
Hydrocodone | Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Suvorexant | Suvorexant Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
Edoxaban | Edoxaban Almotriptan may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Methamphetamine | Methamphetamine The metabolism of Almotriptan can be decreased when combined with Metamfetamine. |
Tasimelteon | Tasimelteon The risk or severity of adverse effects can be increased when Almotriptan is combined with Tasimelteon. |
Riociguat | Riociguat The metabolism of Riociguat can be decreased when combined with Almotriptan. |
Secukinumab Injection | Secukinumab Injection The metabolism of Almotriptan can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Almotriptan. |
Lenvatinib | Lenvatinib The metabolism of Almotriptan can be decreased when combined with Lenvatinib. |
Naloxegol | Naloxegol The metabolism of Almotriptan can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Almotriptan can be decreased when combined with Panobinostat. |
Haloperidol Injection | Haloperidol Injection The risk or severity of CNS depression can be increased when Almotriptan is combined with Haloperidol. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Almotriptan may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Flibanserin | Flibanserin The risk or severity of adverse effects can be increased when Almotriptan is combined with Flibanserin. |
Rolapitant | Rolapitant The metabolism of Almotriptan can be decreased when combined with Rolapitant. |
Brexpiprazole | Brexpiprazole The risk or severity of adverse effects can be increased when Almotriptan is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Almotriptan. |
Cariprazine | Cariprazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Almotriptan may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Eluxadoline. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Almotriptan. |
Ixazomib | Ixazomib Almotriptan may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Rifapentine | Rifapentine The metabolism of Almotriptan can be increased when combined with Rifapentine. |
Lesinurad | Lesinurad Almotriptan may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Almotriptan can be increased when combined with Dexamethasone. |
Brivaracetam Injection | Brivaracetam Injection The risk or severity of adverse effects can be increased when Almotriptan is combined with Brivaracetam. |
Cobicistat | Cobicistat The metabolism of Almotriptan can be decreased when combined with Cobicistat. |
Midodrine | Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Almotriptan. |
Selexipag | Selexipag The metabolism of Selexipag can be decreased when combined with Almotriptan. |
Pimavanserin | Pimavanserin The risk or severity of adverse effects can be increased when Almotriptan is combined with Pimavanserin. |
Diphenhydramine Injection | Diphenhydramine Injection The risk or severity of adverse effects can be increased when Almotriptan is combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Furosemide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Rucaparib | Rucaparib The metabolism of Almotriptan can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection Almotriptan may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Ribociclib | Ribociclib The metabolism of Almotriptan can be decreased when combined with Ribociclib. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be decreased when combined with Almotriptan. |
Doxepin (Insomnia) | Doxepin (Insomnia) Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Doxepin. |
Deutetrabenazine | Deutetrabenazine Almotriptan may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Almotriptan may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Safinamide | Safinamide The metabolism of Almotriptan can be decreased when combined with Safinamide. |
Naldemedine | Naldemedine Almotriptan may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Almotriptan can be decreased when combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Almotriptan can be decreased when combined with Enasidenib. |
Benznidazole | Benznidazole Almotriptan may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Delafloxacin | Delafloxacin Almotriptan may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Letermovir | Letermovir The metabolism of Almotriptan can be decreased when combined with Letermovir. |
Tetrabenazine | Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Almotriptan. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Buprenorphine Injection | Buprenorphine Injection Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
Apalutamide | Apalutamide The metabolism of Apalutamide can be decreased when combined with Almotriptan. |
Avatrombopag | Avatrombopag The metabolism of Almotriptan can be increased when combined with Avatrombopag. |
Baricitinib | Baricitinib Almotriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The therapeutic efficacy of Almotriptan can be increased when used in combination with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Almotriptan may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The metabolism of Almotriptan can be decreased when combined with Eliglustat. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Almotriptan. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Almotriptan. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Almotriptan. |
Cannabidiol | Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Almotriptan. |
Dacomitinib | Dacomitinib The metabolism of Almotriptan can be decreased when combined with Dacomitinib. |
Stiripentol | Stiripentol The metabolism of Almotriptan can be decreased when combined with Stiripentol. |
Gilteritinib | Gilteritinib The therapeutic efficacy of Almotriptan can be decreased when used in combination with Gilteritinib. |
Glasdegib | Glasdegib The metabolism of Glasdegib can be decreased when combined with Almotriptan. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Almotriptan. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Almotriptan. |
Rifamycin | Rifamycin The metabolism of Almotriptan can be decreased when combined with Rifamycin. |
Prucalopride | Prucalopride Almotriptan may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Almotriptan can be increased when combined with Emapalumab. |
Siponimod | Siponimod The risk or severity of hypertension can be increased when Almotriptan is combined with Siponimod. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Alpelisib | Alpelisib The metabolism of Almotriptan can be decreased when combined with Alpelisib. |
Brexanolone Injection | Brexanolone Injection The risk or severity of adverse effects can be increased when Almotriptan is combined with Brexanolone. |
Solriamfetol | Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Almotriptan. |
Triclabendazole | Triclabendazole The metabolism of Almotriptan can be decreased when combined with Triclabendazole. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Almotriptan. |
Pitolisant | Pitolisant The serum concentration of Almotriptan can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Almotriptan can be decreased when combined with Fedratinib. |
Phenytoin Injection | Phenytoin Injection The metabolism of Almotriptan can be decreased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Almotriptan. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Almotriptan is combined with Lumateperone. |
Lasmiditan | Lasmiditan The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Lasmiditan. |
Cenobamate | Cenobamate The serum concentration of Almotriptan can be decreased when it is combined with Cenobamate. |
Ozanimod | Ozanimod The metabolism of Ozanimod can be decreased when combined with Almotriptan. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Almotriptan. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Almotriptan. |
Selpercatinib | Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Almotriptan. |
Lemborexant | Lemborexant The risk or severity of adverse effects can be increased when Almotriptan is combined with Lemborexant. |
Fenfluramine | Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Almotriptan. |
Pralsetinib | Pralsetinib The metabolism of Almotriptan can be decreased when combined with Pralsetinib. |
Opicapone | Opicapone The metabolism of Almotriptan can be decreased when combined with Opicapone. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Almotriptan can be decreased when it is combined with Satralizumab. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Almotriptan is combined with Naxitamab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Viloxazine. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Almotriptan can be decreased when combined with Theophylline. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Indomethacin | Indomethacin Indomethacin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid The metabolism of Almotriptan can be decreased when combined with Mefenamic acid. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Trazodone | Trazodone The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Almotriptan. |
Isotretinoin | Isotretinoin Almotriptan may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Sucralfate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The metabolism of Almotriptan can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine Floxuridine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Phenobarbital | Phenobarbital The metabolism of Almotriptan can be increased when combined with Phenobarbital. |
Metaxalone | Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Almotriptan. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Almotriptan. |
Primidone | Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Almotriptan. |
Methsuximide | Methsuximide The risk or severity of adverse effects can be increased when Almotriptan is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of adverse effects can be increased when Almotriptan is combined with Diethylpropion. |
Chlorpromazine | Chlorpromazine The metabolism of Almotriptan can be decreased when combined with Chlorpromazine. |
Diazepam | Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Almotriptan. |
Oxazepam | Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Almotriptan. |
Flurazepam | Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Almotriptan. |
Clorazepate | Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Almotriptan. |
Lorazepam | Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Almotriptan. |
Phenoxybenzamine | Phenoxybenzamine The risk or severity of hypertension can be increased when Almotriptan is combined with Phenoxybenzamine. |
Carmustine | Carmustine Carmustine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Amantadine | Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Almotriptan. |
Codeine | Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Almotriptan. |
Meprobamate | Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Almotriptan. |
Chlordiazepoxide | Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Almotriptan. |
Bromocriptine | Bromocriptine Almotriptan may increase the vasoconstricting activities of Bromocriptine. |
Metaproterenol | Metaproterenol The risk or severity of hypertension can be increased when Orciprenaline is combined with Almotriptan. |
Tranylcypromine | Tranylcypromine The metabolism of Almotriptan can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine The metabolism of Almotriptan can be decreased when combined with Phenelzine. |
Procarbazine | Procarbazine The metabolism of Almotriptan can be decreased when combined with Procarbazine. |
Ergoloid Mesylates | Ergoloid Mesylates Ergoloid mesylate may increase the vasoconstricting activities of Almotriptan. |
Tetracycline | Tetracycline Tetracycline may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Minocycline | Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Prochlorperazine | Prochlorperazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Prochlorperazine. |
Thioridazine | Thioridazine The metabolism of Almotriptan can be decreased when combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Trifluoperazine. |
Bleomycin | Bleomycin Bleomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dapsone | Dapsone The metabolism of Almotriptan can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine The metabolism of Almotriptan can be decreased when combined with Sulfadiazine. |
Oxycodone | Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Almotriptan. |
Methadone | Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Almotriptan. |
Oxybutynin | Oxybutynin The metabolism of Almotriptan can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Maprotiline | Maprotiline Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Maprotiline. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Trihexyphenidyl | Trihexyphenidyl Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl. |
Orphenadrine | Orphenadrine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
Perphenazine | Perphenazine The metabolism of Almotriptan can be decreased when combined with Perphenazine. |
Azathioprine | Azathioprine Almotriptan may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Fluphenazine. |
Phentermine | Phentermine The metabolism of Almotriptan can be decreased when combined with Phentermine. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Amoxapine | Amoxapine The metabolism of Amoxapine can be decreased when combined with Almotriptan. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Hydrocortisone | Hydrocortisone The metabolism of Almotriptan can be increased when combined with Hydrocortisone. |
Doxorubicin | Doxorubicin The metabolism of Almotriptan can be decreased when combined with Doxorubicin. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Carbamazepine | Carbamazepine Carbamazepine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Almotriptan is combined with Molindone. |
Methyldopa | Methyldopa Almotriptan may decrease the excretion rate of Methyldopa which could result in a higher serum level. |
Clonidine | Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Almotriptan. |
Prazosin | Prazosin Almotriptan may decrease the antihypertensive activities of Prazosin. |
Hydralazine | Hydralazine Almotriptan may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine The metabolism of Almotriptan can be decreased when combined with Cimetidine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Warfarin | Warfarin Warfarin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Clonazepam | Clonazepam The risk or severity of adverse effects can be increased when Almotriptan is combined with Clonazepam. |
Loperamide | Loperamide The metabolism of Almotriptan can be decreased when combined with Loperamide. |
Promethazine | Promethazine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Promethazine. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Griseofulvin | Griseofulvin The metabolism of Almotriptan can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Almotriptan may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Almotriptan. |
Chloroquine | Chloroquine The metabolism of Almotriptan can be decreased when combined with Chloroquine. |
Quinine | Quinine The metabolism of Almotriptan can be decreased when combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Almotriptan. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Sulfinpyrazone | Sulfinpyrazone The metabolism of Almotriptan can be decreased when combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Metolazone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Secobarbital | Secobarbital The metabolism of Almotriptan can be increased when combined with Secobarbital. |
Desipramine | Desipramine The metabolism of Desipramine can be decreased when combined with Almotriptan. |
Amitriptyline | Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Almotriptan. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Almotriptan. |
Probenecid | Probenecid The metabolism of Probenecid can be increased when combined with Almotriptan. |
Quinidine | Quinidine The metabolism of Almotriptan can be decreased when combined with Quinidine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Almotriptan. |
Isoniazid | Isoniazid The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Isoniazid. |
Pyrazinamide | Pyrazinamide Pyrazinamide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Rifampin | Rifampin The metabolism of Almotriptan can be increased when combined with Rifampicin. |
Disopyramide | Disopyramide Disopyramide may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Valproic Acid | Valproic Acid The metabolism of Almotriptan can be decreased when combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Almotriptan can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Almotriptan. |
Levothyroxine | Levothyroxine The metabolism of Almotriptan can be decreased when combined with Levothyroxine. |
Liothyronine | Liothyronine Liothyronine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Methimazole | Methimazole The metabolism of Almotriptan can be decreased when combined with Methimazole. |
Chlorpropamide | Chlorpropamide Chlorpropamide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Tolbutamide | Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Almotriptan. |
Tolazamide | Tolazamide Tolazamide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dextromethorphan | Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Almotriptan. |
Cyclobenzaprine | Cyclobenzaprine The risk or severity of CNS depression can be increased when Almotriptan is combined with Cyclobenzaprine. |
Niacin | Niacin The metabolism of Almotriptan can be decreased when combined with Niacin. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Almotriptan. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Cyproheptadine | Cyproheptadine The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Almotriptan. |
Clemastine | Clemastine The metabolism of Almotriptan can be decreased when combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The risk or severity of adverse effects can be increased when Almotriptan is combined with Chlorpheniramine. |
Brompheniramine | Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Almotriptan. |
Meclizine | Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Almotriptan. |
Ethambutol | Ethambutol Ethambutol may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dantrolene | Dantrolene The risk or severity of adverse effects can be increased when Almotriptan is combined with Dantrolene. |
Chlorzoxazone | Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Almotriptan. |
Carisoprodol | Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Almotriptan. |
Methocarbamol | Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Almotriptan. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The metabolism of Almotriptan can be decreased when combined with Propranolol. |
Minoxidil | Minoxidil Almotriptan may decrease the antihypertensive activities of Minoxidil. |
Pseudoephedrine | Pseudoephedrine The metabolism of Almotriptan can be decreased when combined with Pseudoephedrine. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Almotriptan. |
Spironolactone | Spironolactone The metabolism of Almotriptan can be decreased when combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Phytonadione | Phytonadione Almotriptan may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nadolol | Nadolol Almotriptan may decrease the excretion rate of Nadolol which could result in a higher serum level. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Almotriptan. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Almotriptan. |
Allopurinol | Allopurinol Allopurinol may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Trimethobenzamide | Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Almotriptan. |
Flavoxate | Flavoxate Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Flavoxate. |
Fluorouracil Injection | Fluorouracil Injection The metabolism of Almotriptan can be decreased when combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Almotriptan can be decreased when combined with Colchicine. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Dacarbazine | Dacarbazine Dacarbazine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Almotriptan. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ketoconazole | Ketoconazole The metabolism of Almotriptan can be decreased when combined with Ketoconazole. |
Pyrantel | Pyrantel The risk or severity of adverse effects can be increased when Almotriptan is combined with Pyrantel. |
Captopril | Captopril Almotriptan may decrease the antihypertensive activities of Captopril. |
Isoxsuprine | Isoxsuprine The risk or severity of hypertension can be increased when Almotriptan is combined with Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Almotriptan can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Metoprolol | Metoprolol The metabolism of Almotriptan can be decreased when combined with Metoprolol. |
Hydroxyzine | Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Almotriptan is combined with Thiothixene. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Alprazolam | Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Almotriptan. |
Temazepam | Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Almotriptan. |
Triazolam | Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Almotriptan. |
Dicyclomine | Dicyclomine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Hyoscyamine | Hyoscyamine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine. |
Propantheline | Propantheline Propantheline may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Trimethoprim | Trimethoprim The metabolism of Almotriptan can be decreased when combined with Trimethoprim. |
Diltiazem | Diltiazem The metabolism of Almotriptan can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Almotriptan can be decreased when combined with Nifedipine. |
Timolol | Timolol Timolol may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Verapamil | Verapamil The metabolism of Almotriptan can be decreased when combined with Verapamil. |
Atenolol | Atenolol The metabolism of Almotriptan can be decreased when combined with Atenolol. |
Pindolol | Pindolol The risk or severity of adverse effects can be increased when Almotriptan is combined with Pindolol. |
Cisplatin Injection | Cisplatin Injection Almotriptan may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Bumetanide | Bumetanide Bumetanide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Glipizide | Glipizide Almotriptan may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Indapamide | Indapamide Indapamide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Almotriptan may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Oxacillin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Pentoxifylline may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Pentamidine Injection | Pentamidine Injection Pentamidine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Labetalol | Labetalol The metabolism of Almotriptan can be decreased when combined with Labetalol. |
Auranofin | Auranofin Almotriptan may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Leuprolide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil The metabolism of Almotriptan can be decreased when combined with Gemfibrozil. |
Guanabenz | Guanabenz The risk or severity of hypertension can be increased when Guanabenz is combined with Almotriptan. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Almotriptan can be decreased when combined with Pimozide. |
Enalapril | Enalapril Almotriptan may decrease the antihypertensive activities of Enalapril. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Amiodarone | Amiodarone The metabolism of Amiodarone can be decreased when combined with Almotriptan. |
Aztreonam Injection | Aztreonam Injection Aztreonam may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Buspirone | Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Almotriptan. |
Lovastatin | Lovastatin The metabolism of Almotriptan can be decreased when combined with Lovastatin. |
Ciprofloxacin | Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Fluoxetine | Fluoxetine The serum concentration of Almotriptan can be increased when it is combined with Fluoxetine. |
Nimodipine | Nimodipine Almotriptan may decrease the antihypertensive activities of Nimodipine. |
Clozapine | Clozapine The metabolism of Clozapine can be decreased when combined with Almotriptan. |
Estazolam | Estazolam The risk or severity of adverse effects can be increased when Almotriptan is combined with Estazolam. |
Idarubicin | Idarubicin The metabolism of Idarubicin can be decreased when combined with Almotriptan. |
Didanosine | Didanosine Didanosine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Pentostatin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Clarithromycin | Clarithromycin The metabolism of Almotriptan can be decreased when combined with Clarithromycin. |
Benazepril | Benazepril Almotriptan may decrease the antihypertensive activities of Benazepril. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Felodipine | Felodipine The metabolism of Almotriptan can be decreased when combined with Felodipine. |
Fosinopril | Fosinopril Fosinopril may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Quinapril | Quinapril Almotriptan may decrease the antihypertensive activities of Quinapril. |
Ramipril | Ramipril Almotriptan may decrease the antihypertensive activities of Ramipril. |
Simvastatin | Simvastatin The metabolism of Almotriptan can be decreased when combined with Simvastatin. |
Amlodipine | Amlodipine Almotriptan may decrease the antihypertensive activities of Amlodipine. |
Itraconazole | Itraconazole The metabolism of Almotriptan can be decreased when combined with Itraconazole. |
Lisinopril | Lisinopril Lisinopril may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Rifabutin | Rifabutin The metabolism of Almotriptan can be increased when combined with Rifabutin. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Almotriptan. |
Bisoprolol | Bisoprolol Bisoprolol may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Zolpidem | Zolpidem Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
Doxazosin | Doxazosin Almotriptan may decrease the antihypertensive activities of Doxazosin. |
Terazosin | Terazosin Almotriptan may decrease the antihypertensive activities of Terazosin. |
Isradipine | Isradipine Isradipine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Omeprazole | Omeprazole The metabolism of Almotriptan can be decreased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Almotriptan can be decreased when combined with Cisapride. |
Gabapentin | Gabapentin The risk or severity of adverse effects can be increased when Almotriptan is combined with Gabapentin. |
Fluvastatin | Fluvastatin The metabolism of Almotriptan can be decreased when combined with Fluvastatin. |
Venlafaxine | Venlafaxine The metabolism of Almotriptan can be decreased when combined with Venlafaxine. |
Fluvoxamine | Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Almotriptan. |
Nefazodone | Nefazodone The metabolism of Almotriptan can be decreased when combined with Nefazodone. |
Lamotrigine | Lamotrigine Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan. |
Losartan | Losartan The metabolism of Almotriptan can be decreased when combined with Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Tramadol | Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Almotriptan. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Almotriptan can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Moexipril | Moexipril Almotriptan may decrease the antihypertensive activities of Moexipril. |
Lansoprazole | Lansoprazole The metabolism of Almotriptan can be decreased when combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Almotriptan. |
Nicardipine | Nicardipine The metabolism of Almotriptan can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The metabolism of Almotriptan can be decreased when combined with Bupropion. |
Ticlopidine | Ticlopidine The metabolism of Almotriptan can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir The metabolism of Saquinavir can be decreased when combined with Almotriptan. |
Metformin | Metformin Metformin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nisoldipine | Nisoldipine Almotriptan may decrease the excretion rate of Nisoldipine which could result in a higher serum level. |
Lamivudine | Lamivudine Lamivudine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Riluzole | Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Almotriptan. |
Acarbose | Acarbose Acarbose may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Anastrozole | Anastrozole The metabolism of Anastrozole can be decreased when combined with Almotriptan. |
Gemcitabine Injection | Gemcitabine Injection Gemcitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ritonavir | Ritonavir The metabolism of Almotriptan can be decreased when combined with Ritonavir. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Meropenem may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Almotriptan. |
Zafirlukast | Zafirlukast The metabolism of Almotriptan can be decreased when combined with Zafirlukast. |
Fosfomycin | Fosfomycin Fosfomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Mirtazapine | Mirtazapine Almotriptan may increase the serotonergic activities of Mirtazapine. |
Trandolapril | Trandolapril Almotriptan may decrease the antihypertensive activities of Trandolapril. |
Topiramate | Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Almotriptan. |
Valsartan | Valsartan Almotriptan may decrease the antihypertensive activities of Valsartan. |
Pramipexole | Pramipexole Almotriptan may increase the sedative activities of Pramipexole. |
Donepezil | Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Almotriptan. |
Nelfinavir | Nelfinavir The metabolism of Almotriptan can be decreased when combined with Nelfinavir. |
Loratadine | Loratadine The metabolism of Almotriptan can be decreased when combined with Loratadine. |
Carvedilol | Carvedilol Almotriptan may decrease the antihypertensive activities of Carvedilol. |
Nilutamide | Nilutamide The metabolism of Almotriptan can be decreased when combined with Nilutamide. |
Flutamide | Flutamide Flutamide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Selegiline | Selegiline The metabolism of Almotriptan can be decreased when combined with Selegiline. |
Bicalutamide | Bicalutamide The metabolism of Almotriptan can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline. |
Propafenone | Propafenone The metabolism of Almotriptan can be decreased when combined with Propafenone. |
Raloxifene | Raloxifene The metabolism of Almotriptan can be decreased when combined with Raloxifene. |
Irbesartan | Irbesartan The metabolism of Almotriptan can be decreased when combined with Irbesartan. |
Tamsulosin | Tamsulosin Tamsulosin may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Ropinirole | Ropinirole Almotriptan may increase the sedative activities of Ropinirole. |
Finasteride | Finasteride The risk or severity of hypertension can be increased when Almotriptan is combined with Finasteride. |
Quetiapine | Quetiapine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Almotriptan. |
Paroxetine | Paroxetine The risk or severity of serotonin syndrome can be increased when Paroxetine is combined with Almotriptan. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Almotriptan. |
Citalopram | Citalopram The risk or severity of adverse effects can be increased when Almotriptan is combined with Citalopram. |
Capecitabine | Capecitabine Almotriptan may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Efavirenz | Efavirenz The metabolism of Almotriptan can be decreased when combined with Efavirenz. |
Abacavir | Abacavir Almotriptan may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Sildenafil | Sildenafil The metabolism of Almotriptan can be decreased when combined with Sildenafil. |
Pioglitazone | Pioglitazone The metabolism of Almotriptan can be decreased when combined with Pioglitazone. |
Celecoxib | Celecoxib The metabolism of Almotriptan can be decreased when combined with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Almotriptan can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Tolterodine. |
Thalidomide | Thalidomide Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Nateglinide | Nateglinide Nateglinide may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Galantamine | Galantamine The metabolism of Almotriptan can be decreased when combined with Galantamine. |
Levetiracetam | Levetiracetam The risk or severity of adverse effects can be increased when Almotriptan is combined with Levetiracetam. |
Rabeprazole | Rabeprazole The metabolism of Almotriptan can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Almotriptan can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists